Dr. Gallin was appointed director of the NIH Clinical Center with a dual appointment as NIH associate director for clinical research in 1994. During his tenure a new research hospital for the Clinical Center, the Mark O. Hatfield Clinical Research Center, has been conceived, designed, constructed and made ready for move in. The NIH Clinical Center serves the clinical research needs of 17 institutes and is the largest clinical research hospital in the world.
While serving as Clinical Center director, Dr. Gallin has remained an active clinician and researcher. His primary research interest is in a rare hereditary immune disorder, chronic granulomatous disease. His laboratory has described the genetic basis for several forms of CGD and has done pioneering research that has reduced life-threatening bacterial and fungal infections in CGD patients. He has published more than 290 articles in scientific journals and has edited 2 textbooks.
Dr. Gallin graduated cum laude from Amherst College and earned an M.D. degree at Cornell University Medical College. After a medical internship and residency at New York University's Bellevue Hospital Medical Center, he received postdoctoral training in basic and clinical research in infectious diseases at NIH from 1971-1974. He then served at Bellevue as senior chief medical resident for 2 years before returning to NIH.
In 1985, Dr. Gallin began a 9-year period as scientific director of intramural activities at the National Allergy and Infectious Diseases Institute; he also was chief of NIAID's Laboratory of Host Defenses from 1991 to 2003, and he continues as chief of the lab's clinical pathology section.
Among Dr. Gallin's many awards and honors, the U.S. Public Health Service named him Physician Executive of the Year in 2001. In 2002, the Society for Leukocyte Biology gave him its Bonazinga Award for lifetime achievement in research. He holds memberships in the American Society for Clinical Investigation, Association of American Physicians, and Institute of Medicine of the National Academy of Sciences.
Medicine
for the Public home
|
